Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in japanese and white patients with mild to moderate Alzheimer disease

Kazunori Uenaka, Masako Nakano, Brian A. Willis, Stuart Friedrich, Lisa Ferguson-Sells, Robert A. Dean, Ichiro Ieiri, Eric R. Siemers

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)

Fingerprint Dive into the research topics of 'Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in japanese and white patients with mild to moderate Alzheimer disease'. Together they form a unique fingerprint.

Medicine & Life Sciences